Quest PharmaTech Inc.

C$0.03As of Sun 8 Nov 2026, 12:00 UTC
TSXV:QPTHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (12.00%)
Div yield —
ROE 19.95%
Biotechnology
Beta (5Y) (0.46)
PE TTM 0.870
TSR TTM (37.50%)
Mkt cap C$4.228M
ROIC (1.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0288
15.19%
(6.48%)
Hold 3|5|11|3|1
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
8.46%
14.70%
13.88%
11.86%
Revenue$M
0.193
0.197
0.199
0.196
0.79%
4.45%
4.82%
2.02%
Peers (US$2.993M)
Cap (US$)
PE
2.990M
—
Capital
TTM
5Y
10Y
Leveragex
1.084
0.071
0.065
EBIT/Intx
4.619
0.178
0.201
Own earn%
21.64
(44.40)
(47.24)
Sh yield%
39.01
16.70
15.43
Owners
Insiders/Inst%
3.55
20.92
Short interest%
2.22
SBC / revenue%
3.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
37–42
$1 testx
—
Incr. ROIC%
0